Neuron Specific Enolase (NSE)
Back to Test Catalogue
Neuron Specific Enolase (NSE), Serum
Test ID: NSE S
Test
Method
Enzyme Immunoassay
Report Includes
Specimens
Serum
Clinical Utility
Elevated levels of serum NSE are reported in patients with small cell carcinomas primarily of lung origin. Patients with neuroblastomas may
also have high levels of NSE. Serum NSE can be used to monitor recurrence or progression of tumor in these cancer patients. Daily serial
monitoring of serum NSE may also be used in comatose patients to assess neuronal damage. High NSE levels in comatose patients at 24
and 48 hours post cardio-pulmonary resuscitation have been associated with poor outcome. Hemolysis can cause false positive results.
Test Location
Quest Diagnostics, California USA
Test Version
25-Aug-2022
Specimen
Specimens
Serum
Sample Volume
1 mL
Minimum Volume
0.3 mL
Collection & Handling
Handling Information
Store and send refrigerated.
Stability
| Ambient | 7 days |
|---|---|
| Refrigerated | 7 days |
| Frozen | 30 days |
Test Version
25-Aug-2022
Performance / Interpretation
Method
Enzyme Immunoassay
Turnaround Time
6 days
Results
| Name | Units | Reference Range | Conversion Factor | |
|---|---|---|---|---|
| Neuron Specific Enolase | ng/mL |
|
||
Test Location
Quest Diagnostics, California USA
Test Version
25-Aug-2022
Interface / Setup
Test Version
25-Aug-2022